News
-
-
-
PRESS RELEASE
Galimedix Therapeutics establishes Scientific Advisory Board of renowned retina experts as company prepares to enter Phase 2 clinical study with GAL-101
Galimedix Therapeutics forms Scientific Advisory Board of retina experts to guide Phase 2 study with GAL-101 eye drops for dry AMD, addressing unmet medical need -
PRESS RELEASE
JTC Team Announces Participating Company Line-Up for the Virtual Investor Pitch Conference on June 17-18, 2024
JTC Team to host Virtual Investor Pitch Conference on June 17-18, 2024, featuring live webcast presentations with Q&A sessions. Participating companies include Adolore BioTherapeutics, CNS Pharmaceuticals, Palisade Bio, AIM ImmunoTech, enVVeno Medical, Royalty Management Holding, GRI Bio, Outlook Therapeutics, American Resources Corp, and Moleculin Biotech -
PRESS RELEASE
Gold Terra Announces 2024 Annual General and Special Meeting Results and Deep Drilling Update
Gold Terra Resource Corp. announces approval of matters at Annual General and Special Meeting, new directors elected, and progress update on Con Mine Option Property drilling targeting high-grade gold mineralization -
-
-
-
-